1. Home
  2. FJET vs NTHI Comparison

FJET vs NTHI Comparison

Compare FJET & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Starfighters Space Inc. Common Stock

FJET

Starfighters Space Inc. Common Stock

N/A

Current Price

$1.76

Market Cap

102.8M

ML Signal

N/A

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$3.09

Market Cap

106.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FJET
NTHI
Founded
2022
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.8M
106.0M
IPO Year
2026
2023

Fundamental Metrics

Financial Performance
Metric
FJET
NTHI
Price
$1.76
$3.09
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
★ 1.6M
177.7K
Earning Date
11-14-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $39,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.67
$2.96
52 Week High
$28.56
$12.99

Technical Indicators

Market Signals
Indicator
FJET
NTHI
Relative Strength Index (RSI) 26.86 43.54
Support Level N/A $3.03
Resistance Level $2.10 $3.70
Average True Range (ATR) 0.16 0.34
MACD 0.06 0.00
Stochastic Oscillator 33.49 36.84

Price Performance

Historical Comparison
FJET
NTHI

About FJET Starfighters Space Inc. Common Stock

Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida, with an additional base of operations at Midland International Air & Space Port in Texas, and has a fleet of seven F-104 Fighter jets that are capable of flying MACH 2+. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company has one operating segment, which is principally the operations of F-104 Fighter jets and the development of infrastructure for orbital space launch.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: